Privia Health Net Income vs. Return On Equity
| PRVA Stock | USD 22.03 0.00 0.00% |
Net Income | First Reported 2020-03-31 | Previous Quarter 6.9 M | Current Value 9.2 M | Quarterly Volatility 36.7 M |
Macro event markers
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0733 | 0.094 |
|
|
Profitability ratios here explain how Privia Health converts sales and assets into earnings and performance context.
Privia Health's Revenue Mix by Segment
Privia Health generates revenue across 6 reported product segments. FFS-Patient Care accounts for approximately 67.3% of Privia Health's revenue at 364.41 Million, while Capitated Revenue contributes 13.2% at 71.35 Million. Revenue concentration above 60% in one segment means Privia Health's performance is closely tied to that product's market dynamics.
Your Equity Center.
Macro event markers
Earnings Segment Revenue Breakdown for Privia Health View
The breakdown below shows how Privia Health's revenue is split across product segments for the most recent reporting period. Other Revenue rounds out the mix at 0.5%, representing Privia Health's smallest reported product line.
These estimates offer context for valuation and trend interpretation. The estimates are presented as context for broader analysis and timeframe comparison.
Quarterly Earnings Growth 1.328 | Earnings Share 0.18 | Revenue Per Share | Quarterly Revenue Growth 0.174 | Return On Assets |
Understanding Privia Health Group includes distinguishing between market value and book value, where book value reflects Privia's accounting equity. Privia Health's market capitalization is 2.68 B. At P/B 3.64, Privia Health trades at a significant premium to book value. Enterprise value stands at 2.21 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
It is useful to distinguish Privia Health's value from its trading price, which are computed with different methods. For Privia Health, key inputs include a P/B ratio of 3.64, a profit margin of 1.08%, ROE of 4.03%, and revenue of 2.12 B. Privia Health market price reflects the current exchange level formed by active bids and offers.
Privia Health Group Return On Equity vs. Net Income Fundamental Analysis
Sector-based pricing multiples position Privia Health within its competitive valuation range. Privia Health Group is rated fourth in net income among leading competitors. It is rated second in return on equity among leading competitors . At 568,709,677 , Privia Health Group's Net Income-to-Return On Equity multiple reflects the spread between these metrics. Recent filings indicate that Net Income continues pushing upward. Year-ago financials show Privia Health with Net Income of 22.92 Million. Peer multiple ratios estimate Privia Health's valuation standing.Privia Return On Equity vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Privia Health |
| = | 22.92 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Return on Equity (ROE) measures how effectively a company converts shareholders' equity into net income. It is calculated by dividing net income by average shareholders' equity, and it reflects management's ability to generate profit from the capital investors have committed. ROE is one of the most widely used profitability ratios because it ties directly to shareholder value creation.
Privia Health |
| = | 0.0403 |
An ROE between 10% and 30% is generally considered healthy for most industries, supporting both dividend payments and reinvestment in future growth. However, ROE should not be evaluated in isolation. A high ROE driven by excessive financial leverage can signal risk rather than efficiency, so investors typically cross-reference ROE with debt-to-equity ratios and return on assets to distinguish genuine operational strength from balance-sheet amplification.
Privia Return On Equity Comparison
Privia Health is currently under evaluation in return on equity among leading competitors.
Privia Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Privia Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Privia Health will eventually generate negative long term returns. The profitability progress is the general direction of Privia Health's change in net profit over the period of time. It can combine multiple indicators of Privia Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 9.7 M | 10.2 M | |
| Operating Income | 34.2 M | 35.9 M | |
| Net Income From Continuing Ops | 29.7 M | 31.2 M | |
| Income Before Tax | 43.9 M | 46.1 M | |
| Total Other Income Expense Net | 9.7 M | 10.2 M | |
| Net Loss | -7.7 M | -8.1 M | |
| Net Income | 22.9 M | 24.1 M | |
| Income Tax Expense | 14.2 M | 14.9 M | |
| Change To Netincome | 69.4 M | 60.8 M | |
| Net Income Per Share | 0.19 | 0.20 | |
| Income Quality | 7.13 | 7.49 | |
| Net Income Per E B T | 0.52 | 0.84 |
Privia Profitability Driver Comparison
Profitability drivers for Privia Health are the most direct factors influencing its investment outlook. Investors face numerous unpredictable events - from regulatory changes to macroeconomic disruptions - that can alter Privia Health's financial performance and earnings sustainability at any time.
Earnings per Share Projection vs Actual
Use Privia Health in pair-trading
Using Privia Health in a pair-trading setup can improve risk control because gains and losses are judged against a second position instead of against the market alone. A disciplined pair strategy still requires monitoring because correlation can weaken when market regimes change.
Privia Health Pair Trading
Privia Health Group Pair Trading Analysis
Replacing Privia Health with a highly correlated asset during tax-loss harvesting reduces the probability that the portfolio will miss a sudden rally in Privia Health Group during the required 30-day waiting period.
For long-term investors in Privia Health, the relevant correlation horizon is typically monthly or quarterly. Short-term noise in daily Privia Health Group correlation estimates can be misleading when constructing buy-and-hold diversified portfolios.
Pair evaluation and Correlation analysis for Privia Health provide hedging context. This approach is commonly reviewed within sectors and across broader groups.Use Investing Themes to Complement your Privia Health position
Privia Health Group operates in Healthcare/Health Information Services at 2.68 Billion market cap - a thematic view expands this smaller-cap position into a broader portfolio concept. For Privia Health Group in Health Information Services, the theme workflow defines the investment thesis first, then optimizes which Healthcare assets best express that view at the smaller-cap level.
Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 33 constituents at this time.
The Global Macro ETFs Theme can be deployed as a buy-and-hold allocation or traded actively around individual position volatility.
| View All Next | Launch |
More Resources for Privia Stock Analysis
A structured review of Privia Health Group often starts with core financial statements and trend context. Ratios and trend metrics help frame Privia Health's operating context across reporting periods. Key reports that frame Privia Health Group Stock are listed below:Your Equity Center. Privia Health currently shows ROE of 4.03%, market cap of 2.68 Billion. Privia Health analysis should be paired with portfolio risk and diversification tools before adjusting allocations. For Privia Health, the analytical tools below add portfolio-level context that single-security review alone cannot provide. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Projecting Privia Health's profitability starts with historical financial statements. The three primary statements are income statement, balance sheet, and cash flow.